Copellor 80mg Injection (Ixekizumab)

Copellor 80mg Injection contains Ixekizumab 80mg, a prescription biologic medicine and selective interleukin-17A (IL-17A) inhibitor. It is used to treat certain immune-mediated inflammatory conditions, including moderate-to-severe plaque psoriasis and psoriatic arthritis, as well as other approved inflammatory conditions depending on the patient’s age and local regulatory approval.

Taltz® is the reference brand containing ixekizumab. Copellor 80mg provides the same active ingredient, ixekizumab, and may be marketed as an alternative to Taltz® depending on the applicable regulatory classification.

Product Information

• Brand Name: Copellor
• Generic Name: Ixekizumab
• Strength: 80mg
• Reference Brand: Taltz®
• Drug Class: Biologic / Interleukin-17A (IL-17A) Inhibitor
• Indications: Plaque Psoriasis, Psoriatic Arthritis, and other approved inflammatory conditions
• Dosage Form: Injection
• Route: Subcutaneous Injection
• Prescription: Yes
• Active Ingredient: Ixekizumab
• Packing: Manufacturer Dependent

How It Works

Ixekizumab is a humanized monoclonal antibody that selectively binds to interleukin-17A (IL-17A) and blocks its interaction with the IL-17 receptor.

IL-17A plays an important role in inflammatory and immune responses involved in conditions such as psoriasis and psoriatic arthritis. By inhibiting IL-17A activity, ixekizumab helps reduce inflammation and associated symptoms.

Uses

Copellor 80mg Injection may be prescribed for eligible patients with:

• Moderate-to-severe plaque psoriasis
• Psoriatic arthritis
• Axial spondyloarthritis, where approved
• Ankylosing spondylitis, where approved
• Other approved IL-17A-mediated inflammatory conditions depending on local regulatory authorization

The approved indications can vary by country, age group, and regulatory authority.

Copellor 80mg and Taltz®

Taltz® contains the active ingredient ixekizumab. Copellor 80mg Injection also contains ixekizumab 80mg.

For SEO purposes, the strongest primary product name is:

Copellor 80mg Injection

Supporting terms can include:

• Ixekizumab 80mg Injection
• Ixekizumab Injection
• Taltz® alternative
• Ixekizumab 80mg
• IL-17A inhibitor
• Ixekizumab biologic

The term “generic Taltz®” or “biosimilar Taltz®” should only be used if the specific Copellor product has the corresponding regulatory classification in the target market.

Availability & Ordering

Patients searching for Copellor 80mg Injection, Ixekizumab 80mg Injection, Ixekizumab Injection, Copellor Ixekizumab, Taltz® alternative, Ixekizumab for Psoriasis, Ixekizumab for Psoriatic Arthritis, IL-17A Inhibitor, and Ixekizumab Biologic Medicine can find prescription products through licensed pharmaceutical suppliers, subject to local prescription and pharmaceutical regulations.

Frequently Asked Questions

What is Copellor 80mg Injection used for?

Copellor 80mg contains ixekizumab and is used for certain immune-mediated inflammatory conditions, particularly plaque psoriasis and psoriatic arthritis, according to the approved indications.

What is the active ingredient in Copellor 80mg?

The active ingredient is Ixekizumab 80mg.

Is Copellor 80mg the same as Taltz®?

Both contain ixekizumab as the active ingredient. Taltz® is the reference brand. Whether Copellor is classified as a generic, biosimilar, or another type of alternative depends on the specific product and regulatory approval.

How does Ixekizumab work?

Ixekizumab selectively inhibits IL-17A, an inflammatory cytokine involved in the immune pathways associated with psoriasis and several related inflammatory conditions.

How is Copellor 80mg administered?

Copellor 80mg is administered by subcutaneous injection according to the indication-specific dosing schedule prescribed by a healthcare professional.

Is Copellor 80mg a biologic medicine?

Yes. Ixekizumab is a biologic monoclonal antibody that specifically targets IL-17A.

Does Copellor 80mg require a prescription?

Yes. Ixekizumab is a prescription biologic medicine and should be used under the supervision of a qualified healthcare professional.

Does Ixekizumab require medical monitoring?

Yes. Healthcare professionals generally assess patients for infections and other relevant risks before and during treatment with ixekizumab.

Last Updated: August 20, 2026 | Medically Reviewed By: Licensed Pharmacist

Medical Disclaimer: This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Copellor 80mg Injection should be used only under the supervision of a qualified healthcare professional.